ask="5.85"
ask_size="3000"
average_daily_volume="58498"
bid="4.83"
bid_size="200"
book_value="0.00"
change="+0.00"
change_from_200_day_moving_average="0.73"
change_from_50_day_moving_average="0.46"
change_from_52_week_high="-8.29"
change_From_52_week_low="2.36"
change_in_percent="+0.00%"
close="5.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.27"
ebitda="0.00"
eps_estimate_current_year="-5.06"
eps_estimate_next_quarter="-0.70"
eps_estimate_next_year="-2.28"
ex_dividend_date="N/A"
float_shares="N/A"
high="5.05"
high_52_weeks="13.30"
last_trade_date="3/1/2017"
last_trade_price="5.01"
last_trade_size="108"
last_trade_time="4:00pm"
low="4.94"
low_52_weeks="2.65"
market_capitalization="N/A"
moving_average_200_day="4.28"
moving_average_50_day="4.55"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="6.75"
open="5.01"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+17.07%"
percent_change_from_50_day_moving_average="+10.01%"
percent_change_from_52_week_high="-62.33%"
percent_change_from_52_week_low="+89.06%"
previous_close="5.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CLBS"
volume="12587"
weeks_range_52="2.65 - 13.30"
